eVitamins Vitamin Brands - Baywood - Allergy
Browse our fine Vitamin Brands - Baywood - Allergy selections.
![]() | Dr. Harris' Original Allergy Formula This patented formula contains a unique combination of 100% natural herbs and enzymes extracted by a special process from botanicals. They are tested multiple times to insure only the highest quality ...More Dr. Harris' Original Allergy Formula information here |
Vitamin & Supplement Informatiion News
- Trial finds no benefits from vitamins C and E in cutting risk of heart disease (International Herald Tribune)
A large long-term trial has found that the supplements work no better than placebos.
- Always check with doctor before taking supplements (Rochester Democrat and Chronicle)
Make sure that an ad for free supplements doesn't end up costing you in the long run.
- Breaking News on Supplements & Nutrition - North America (Nutraingredients.com)
Nutraceuticals International LLC. (NI), international ingredient supplier known for Exclusive Nutraceuticals and Specialty Ingredients (US Headquarters: Elmwood Park, NJ USA) and Amruta Herbals Pvt. Ltd. (AHPL), a major manufacturer of the highest quality Ayurvedic Herbal Extracts (GMP Certified / ISO 9000-2001 Certified Facility in INDORE) have announced the formation of a joint venture to ...
- Vitamins Seen as No Help in Heart Disease (New York Times)
A large long-term trial has found that vitamins C and E work no better than placebos at reducing a person?s risk of heart disease.
- Study: Vitamins E and C Fail to Prevent Cancer in Men (The Hendersonville Times-News)
A large clinical trial of almost 15,000 men taking vitamins E and C for up to 10 years has found that neither supplement had any effect on cancer rates.
- Petitions: The new tool to attack supplements (Nutraingredients.com)
The petition filed earlier this year by GSK in an effort to wipe out the dietary supplement category for weight loss is unlikely to pass. But it highlights a major new threat to the industry: The use of petitions to discredit the supplements sector. Lorraine Heller reports.

